Akebia Therapeutics (AKBA) Earnings Date, Estimates & Call Transcripts → Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way (From Small Cap Sniper) (Ad) Free AKBA Stock Alerts $1.25 -0.05 (-3.49%) (As of 11:09 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 23EstimatedActual EPS (May. 9) -$0.09 Consensus EPS (May. 9) -$0.09 Read Call TranscriptListen to Call Get Akebia Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AKBA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAKBA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AKBA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingThe World’s Richest Man Blindsided by AIThese billionaires know that early investors in AI stand to make a lot of money. The same is true for everyday Americans... including you.Get the full story here. Akebia Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.09)($0.09)($0.09)Q2 20241($0.07)($0.07)($0.07)Q3 20241($0.09)($0.09)($0.09)Q4 20241($0.06)($0.06)($0.06)FY 20244($0.31)($0.31)($0.31)AKBA Earnings Date and InformationAkebia Therapeutics last issued its quarterly earnings results on May 9th, 2024. The biopharmaceutical company reported ($0.09) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.09). The firm earned $32.61 million during the quarter, compared to the consensus estimate of $41.13 million. Akebia Therapeutics has generated ($0.23) earnings per share over the last year (($0.23) diluted earnings per share). Earnings for Akebia Therapeutics are expected to grow in the coming year, from ($0.28) to ($0.23) per share. Akebia Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 23rd, 2024 based off prior year's report dates.Read More Akebia Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/23/2024Estimated)------- 5/9/2024Q1 2024($0.09)($0.09)-($0.09)$41.13 million$32.61 million 3/14/2024Q4 2023($0.04)($0.04)--$55.64 million$56.20 million11/8/2023Q3 2023($0.09)($0.08)+$0.01($0.08)$48.19 million$42.05 million 8/25/2023Q2 2023($0.03)($0.06)($0.03)($0.06)$59.10 million$56.38 million 5/8/2023Q1 2023($0.15)($0.14)+$0.01($0.14)$46.69 million$40.13 million 3/9/2023Q4 2022($0.14)($0.04)+$0.10($0.04)$48.35 million$55.18 million Get the Latest News and Ratings for AKBA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akebia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022($0.15)($0.28)($0.13)($0.28)$47.17 million$48.96 million8/4/2022Q2 2022($0.31)$0.23+$0.54$0.31$49.10 million$126.76 million 5/9/2022Q1 2022($0.27)($0.35)($0.08)($0.35)$44.37 million$61.70 million 3/1/2022Q4 2021($0.33)($0.40)($0.07)($0.40)$48.22 million$59.61 million 11/4/2021Q3 2021($0.32)($0.34)($0.02)($0.34)$50.09 million$48.76 million 8/4/2021Q2 2021($0.30)($0.51)($0.21)($0.51)$60.08 million$52.91 million Akebia Therapeutics Earnings - Frequently Asked Questions When is Akebia Therapeutics's earnings date? Akebia Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 23rd, 2024 based off last year's report dates. Learn more on AKBA's earnings history. Did Akebia Therapeutics beat their earnings estimates last quarter? In the previous quarter, Akebia Therapeutics (NASDAQ:AKBA) reported ($0.09) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.09). Learn more on analysts' earnings estimate vs. AKBA's actual earnings. How can I listen to Akebia Therapeutics's earnings conference call? The conference call for Akebia Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Akebia Therapeutics's conference call transcript? The conference call transcript for Akebia Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Akebia Therapeutics generate each year? Akebia Therapeutics (NASDAQ:AKBA) has a recorded annual revenue of $194.62 million. How much profit does Akebia Therapeutics generate each year? Akebia Therapeutics (NASDAQ:AKBA) has a recorded net income of -$51.92 million. AKBA has generated -$0.23 earnings per share over the last four quarters. What is Akebia Therapeutics's EPS forecast for next year? Akebia Therapeutics's earnings are expected to grow from ($0.28) per share to ($0.23) per share in the next year. More Earnings Resources from MarketBeat Related Companies: VSTM Earnings XOMA Earnings INZY Earnings EPIX Earnings ELYM Earnings RAPT Earnings XBIT Earnings XERS Earnings AQST Earnings CTMX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:AKBA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akebia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
